Results 181 to 190 of about 290,506 (328)

Menopause Exposed: Women Surveying Women [PDF]

open access: yes, 2010
Balaam, Marie-clare, Crowther, Barbara
core  

An Interpretable Machine Learning Model for Predicting 5‐Year Survival in Breast Cancer Based on Integration of Proteomics and Clinical Data

open access: yesiMetaMed, EarlyView.
This study first introduced Kolmogorov–Arnold Network (KAN) into the deep learning model for the integration of clinical and proteomics data in predicting 5‐year survival in breast cancer. The optimal predictive model with 13 key predictors demonstrated excellent predictive performance with strong accuracy, precision, and F1.
Zhixuan Wu   +6 more
wiley   +1 more source

Body‐identical estrogens in combined hormonal contraceptives: A safer path forward

open access: yes
International Journal of Gynecology &Obstetrics, EarlyView.
Nathalie Chabbert‐Buffet   +8 more
wiley   +1 more source

Pharmacokinetics and Safety of Fezolinetant in Women with Hepatic or Renal Impairment

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract The neurokinin 3 receptor antagonist fezolinetant is an approved treatment for vasomotor symptoms due to menopause. The impacts of hepatic and renal impairment on the pharmacokinetics and safety of a single oral dose of fezolinetant 30 mg were investigated in two independent studies.
Megumi Iwai   +8 more
wiley   +1 more source

Radiation Risk in 2D Mammography Screening: A Scoping Review of Modelling Strategies and Emerging AI Applications

open access: yesJournal of Medical Radiation Sciences, EarlyView.
This scoping review examined models estimating long‐term radiation risks from repeated mammography screening. While modelling indicates the risks are low, approaches vary by protocol and vendor. Emerging AI tools show promise for improving personalised risk estimation, though further development is needed for cross‐platform compatibility.
Nazli A. Moda   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy